3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
8
Phase 2
6
Phase NA
5
Phase 4
5
Phase 1
2
Phase EARLY_PHASE1
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Pulmonary Embolism
1
Pancreatic Neoplasms
1
Interventions
Cyclophosphamide
416
Radiotherapy
276
fludarabine
238
Gemcitabine
211
Cisplatin
203
Nivolumab
184
pembrolizumab
183
Paclitaxel
176
Carboplatin
168
Magnetic Resonance Spectroscopy
166
fludarabine phosphate
156
Irinotecan
135
Bevacizumab
133
Cytarabine
128
Specimen Handling
124
Capecitabine
124
Temozolomide
123
Radiosurgery
118
Docetaxel
116
Biopsy
116
Ipilimumab
113
Dexamethasone
113
Radiation
111
Oxaliplatin
110
Fluorouracil
110
Rituximab
108
Etoposide
108
Filgrastim
99
Lenalidomide
98
Everolimus
96
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
OTHER
×
apixaban
×
Clear all
NCT04191928
2021-12-23
PAP-UP
Thomas Jefferson University
Phase 1
Completed
4 enrolled
NCT03083782
2017-10-11
ACT
Thomas Jefferson University
Phase 1
Completed
12 enrolled